Ultragenyx Pharmaceutical (RARE) Change in Inventory (2018 - 2026)

Ultragenyx Pharmaceutical (RARE) has 9 years of Change in Inventory data on file, last reported at $4.0 million in Q1 2026.

• On a quarterly basis, Change in Inventory rose 300.0% year-over-year to $4.0 million in Q1 2026; TTM through Mar 2026 was $9.0 million, a 8.87% decrease from a year earlier, with the FY2025 full-year figure at $6.0 million, down 45.45% from the prior year.
• Change in Inventory for Q1 2026 stood at $4.0 million, up from -$150000.0 in the prior quarter.
• Over the last five years, Change in Inventory for RARE reached as high as $5.6 million in Q3 2025 and fell as low as -$445000.0 in Q2 2025.
• Historically, Change in Inventory has averaged $2.2 million across 5 years, with a median of $2.1 million in 2024.
• Across the five-year window, Change in Inventory surged 1782.98% in 2022 and tumbled 110.78% in 2025, its largest moves.
• Year by year, Change in Inventory stood at $4.2 million in 2022, then slumped by 51.82% to $2.0 million in 2023, then rose by 11.01% to $2.2 million in 2024, then sank by 106.67% to -$150000.0 in 2025, then soared by 2766.67% to $4.0 million in 2026.
• Per Business Quant data, the three most recent Change in Inventory figures were $4.0 million in Q1 2026, -$150000.0 in Q4 2025, and $5.6 million in Q3 2025.